Literature DB >> 12775254

Tibetan patients with essential hypertension caused by underlying oxidative metabolism dysfunction and depressed nitric oxide synthesis.

Dangsheng Li1, Xiongwei Wang, Zhongming Fu, Jun Yu, Wenli Da, Shunzhou Peng, Xiangui Wang.   

Abstract

OBJECTIVE: To assess the role of oxidative metabolism and nitric oxide synthesis for elucidating their pathophysiological mechanisms in a Tibetan patient with essential hypertension.
METHODS: The serum levels of total superoxide dismutase (T-SOD), malondialdehyde (MDA), total antioxidant capacity (T-AOC), nitric oxide (NO) and nitric oxide synthase (NOS) were assayed in sixty native Tibetans (thirty hypertensive patients and thirty healthy volunteers as control).
RESULTS: The levels of T-SOD, T-AOC, NO and NOS were significantly lower in the patient group than in the control group (P < 0.01); MDA was significantly higher in the patient group than in the control group (P < 0.01). The level of MDA had a strong negative correlation with T-SOD, T-AOC, NO and NOS (r = -0.82, -0.76, -0.79, -0.73, respectively, P < 0.001 for all).
CONCLUSION: Tibetan patients with essential hypertension (EH) may have underlying oxidative metabolism dysfunction and depressed NO synthesis, both responsible for the hypertensive process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775254

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  A Comparative Study of Baseline Heart Rate Variability, Sleep Quality, and Oxidative Stress Levels in Hypertensive Versus Normotensive Subjects: A Cross-Sectional Study.

Authors:  Prabin Kharibam; Monika Pathania; Manisha Naithani; Yogesh Singh; Yogesh Bahurupi; Minakshi Dhar; Shashi R Yadav; Nitesh Singh
Journal:  Cureus       Date:  2022-06-11

2.  Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension.

Authors:  Aarti S Mahajan; Rashmi Babbar; Nisheeth Kansal; Satish K Agarwal; Prakash C Ray
Journal:  J Clin Biochem Nutr       Date:  2007-03       Impact factor: 3.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.